Rx · Prescription onlyInjected under the skin

Tirzepatide + Glycine + Methylcobalamin

Your plan

1 vial · lasts 4 weeks · 2.15–17 mg tirzepatide, set by your clinician

You'll see the price in your assessment

  • Medication, clinician care and dose adjustments, all in one price.

A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.

FDA status: Compounded medication, not FDA-approved. Its active ingredient, tirzepatide, is also in the FDA-approved drugs Mounjaro and Zepbound; this compounded version is not one of them.

What it's for

Who it's for

People who want tirzepatide with glycine and active B12 together.

How it's different

The fullest tirzepatide blend: the medicine is the same, the add-ons are nutritional support.

How it works

Glycine supports sleep and muscle recovery; methylcobalamin is an active B12 form that powers energy production. Together with tirzepatide, they address appetite (tirzepatide), sleep (glycine), and energy (methylcobalamin).

How to use it and what arrives

1 vial · lasts 4 weeks

Your clinician sets your dose: 2.15–17 mg tirzepatide · same price at every dose

How
Injected under the skin
How often
Once a week

Good to know

The numbers on these vials are unusual (17, 34, 51 mg). Do not compare them with another vial; use only the units on your label.

What the research shows

Tirzepatide acts on two gut hormone receptors, GLP-1 and GIP. Its evidence is large randomized trials in adults with obesity, all with the injected form.

  1. Weight

    about 21%

    SURMOUNT-1: 2,539 adults with obesity, or overweight with a weight-related condition, 72 weeks of weekly injections at 5, 10 or 15 mg. At 15 mg the mean loss was 20.9% (intention to treat), against 3.1% on placebo.

    SURMOUNT-1, NEJM 2022
  2. Head to head

    20.2% vs 13.7%

    SURMOUNT-5: 751 adults without diabetes, open label, 72 weeks. Maximum tolerated tirzepatide (10 or 15 mg) lost 20.2% on average; maximum tolerated semaglutide (1.7 or 2.4 mg) lost 13.7%.

    SURMOUNT-5, NEJM 2025
  3. Large losses

    57% lost 20% or more

    SURMOUNT-1 at 15 mg: 57% of people reached a loss of at least 20% of body weight, against 3% on placebo. The average hides a wide spread between people.

    SURMOUNT-1, NEJM 2022

Trial results are for the injected tirzepatide at the doses studied. They are averages, not predictions for one person. No trial has tested the sublingual (dissolve-under-the-tongue) form or the compounded blends.

What this does not say

  • SURMOUNT-5 was open label and run by the manufacturer of tirzepatide, so the head-to-head result needs an independent check.
  • The trials ran 52 to 72 weeks. Effects after stopping were not part of them, though SURMOUNT-4 shows regain after withdrawal.
  • Between 4.3% and 7.1% of people on tirzepatide stopped for adverse events in SURMOUNT-1, against 2.6% on placebo.

Sources

  1. Once-weekly tirzepatide 2.4 mg produced mean weight loss of up to 21% over 72 weeks in adults with obesity (SURMOUNT-1). NEJM, 2022 (Jastreboff AM et al.)
  2. Methylcobalamin and energy metabolism: B12 as an essential cofactor in mitochondrial function. J Clin Biochem Nutr, 2008
Read the full research

Safety

FDA status: Compounded medication, not FDA-approved. Its active ingredient, tirzepatide, is also in the FDA-approved drugs Mounjaro and Zepbound; this compounded version is not one of them.

Side effects and precautions

  • Tirzepatide plus additives carries tirzepatide's safety profile: nausea, diarrhea, constipation, reduced appetite, and fatigue are common in early weeks.
  • Additives (B6, L-carnitine, glycine, methylcobalamin) are well-tolerated.
  • Not for pregnancy or breastfeeding, or with active pancreatitis.

Get care right away

  • Stop and seek care for severe abdominal pain, allergic reactions, or signs of pancreatitis.

When it isn't prescribed

  • Do not use with medullary thyroid carcinoma history or MEN 2.

Tell your clinician about all medications, diabetes drugs, and any kidney or pancreatic disease.

Questions

Why all three?

Tirzepatide works on appetite and metabolism; glycine on sleep; methylcobalamin on energy. During weight loss, many people struggle with sleep disruption and fatigue. This combination addresses all three for a smoother, more sustainable experience.

Is tirzepatide more powerful than semaglutide?

Tirzepatide (dual GLP-1/GIP) produced larger weight loss in trials (~21% vs. ~15% for semaglutide). However, 'better' depends on your individual response. Your clinician will recommend based on your health profile.

Can I switch between tirzepatide and semaglutide?

Yes. If one doesn't work as well, your clinician can switch you to the other. Doses differ between the two, so the change is made carefully.

Do additives interact with tirzepatide?

No significant interactions. B6, L-carnitine, glycine, and methylcobalamin are natural compounds that complement tirzepatide's action. Your clinician monitors overall response.

What if I only want tirzepatide, no additives?

You can choose tirzepatide alone. The additives are optional enhancements. Your clinician can adjust your plan based on your preferences and needs.

Still have a question? Message our team

Ready to start with Tirzepatide + Glycine + Methylcobalamin?

  • Free shipping on every order
  • No membership fee
  • Same price at every dose
  • HSA and FSA accepted

More options in this area